GAP-43 mRNA expression in the developing rat brain: alterations following lead-acetate exposure
- PMID: 8856737
GAP-43 mRNA expression in the developing rat brain: alterations following lead-acetate exposure
Abstract
The developmental neurotoxicity of environmental lead exposure manifests as alterations in neural functioning and perturbed axonal and dendritic development. To examine the hypothesis that such lead-induced alterations in the neural network are associated with an altered mRNA expression of a specific neural cell growth associated protein, mRNA levels of GAP-43 (growth associated protein 43) were measured in the cortex and hippocampus of developing Long-Evans hooded rats following various lead exposure paradigms. Postnatal developmental profiles (PND 6, 9, 12, 15, 20, and 25) of mRNA expression were generated following either prenatal (gestational day 13 to birth), postnatal (postnatal day 1 to postnatal day 20), or perinatal (gestational day 13 to postnatal day 20) exposure to lead acetate (0.2% in the drinking water of the dam). In control rats, GAP-43 mRNA levels displayed a distinct developmentally regulated profile of expression in both the cortex and hippocampus, characterized by an elevated level of expression within the first week of life. This peak level of expression was significantly depressed following either postnatal or perinatal exposure to lead acetate, while prenatal lead exposure produced an initial elevation of GAP-43 mRNA on postnatal day 6 followed by a sharp decline. These data suggest that lead exposure results in altered mRNA expression of a specific neural cell growth associated protein critical to the normal process of development. This perturbation in expression may play a role in the previously reported effects of lead acetate on axonal elongation during development of the nervous system and the subsequent alteration in nervous system functioning.
Similar articles
-
Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain.Toxicol Appl Pharmacol. 1996 Jul;139(1):84-93. doi: 10.1006/taap.1996.0145. Toxicol Appl Pharmacol. 1996. PMID: 8685912
-
Effects of Brn-3a protein and RNA expression in rat brain following low-level lead exposure during development on spatial learning and memory.Toxicol Lett. 2006 Jun 20;164(1):63-70. doi: 10.1016/j.toxlet.2005.11.011. Epub 2005 Dec 27. Toxicol Lett. 2006. PMID: 16384672
-
Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum.Toxicol Appl Pharmacol. 1996 May;138(1):43-7. doi: 10.1006/taap.1996.0095. Toxicol Appl Pharmacol. 1996. PMID: 8658511
-
Developmental exposure to lead and late life abnormalities of nervous system.Indian J Exp Biol. 2010 Jul;48(7):636-41. Indian J Exp Biol. 2010. PMID: 20929048 Review.
-
Lead and lead compounds.IARC Monogr Eval Carcinog Risk Chem Hum. 1980;23:325-415. IARC Monogr Eval Carcinog Risk Chem Hum. 1980. PMID: 7000667 Review. No abstract available.
Cited by
-
Lead Neurotoxicity on Human Neuroblastoma Cell Line SH-SY5Y is Mediated via Transcription Factor EGR1/Zif268 Induced Disrupted in Scherophernia-1 Activation.Neurochem Res. 2018 Jul;43(7):1308-1316. doi: 10.1007/s11064-018-2539-2. Epub 2018 Jun 4. Neurochem Res. 2018. PMID: 29868983
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous